Giovanni Selvaggi

机构：Xcovery (United States) · ORCID：0000-0001-8015-8999

发表论文 135 篇 · 总被引 5259 次 · h-index 33

代表论文

• Tumor Mutational Burden and Efficacy of Nivolumab Monotherapy and in Combination with Ipilimumab in Small-Cell Lung Cancer (2018 · Cancer Cell · 被引 913)
• Nivolumab and Ipilimumab as Maintenance Therapy in Extensive-Disease Small-Cell Lung Cancer: CheckMate 451 (2021 · Journal of Clinical Oncology · 被引 272)
• Ensartinib vs Crizotinib for Patients With Anaplastic Lymphoma Kinase−Positive Non–Small Cell Lung Cancer (2021 · JAMA Oncology · 被引 260)
• Tumor Mutational Burden and Efficacy of Nivolumab Monotherapy and in Combination with Ipilimumab in Small-Cell Lung Cancer (2019 · Cancer Cell · 被引 222)
• Efficacy, safety, and biomarker analysis of ensartinib in crizotinib-resistant, ALK-positive non-small-cell lung cancer: a multicentre, phase 2 trial (2019 · The Lancet Respiratory Medicine · 被引 139)
• A Phase II Study of Pelareorep (REOLYSIN®) in Combination with Gemcitabine for Patients with Advanced Pancreatic Adenocarcinoma (2018 · Cancers · 被引 137)